These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 31403931)

  • 1. Haemostatic responsiveness and release of biological response modifiers following cryopreservation of platelets treated with amotosalen and ultraviolet A light.
    Tynngård N; Wikman A; Uhlin M; Sandgren P
    Blood Transfus; 2020 May; 18(3):191-199. PubMed ID: 31403931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cryopreservation of buffy coat-derived platelet concentrates photochemically treated with amotosalen and UVA light.
    Meinke S; Wikman A; Gryfelt G; Hultenby K; Uhlin M; Höglund P; Sandgren P
    Transfusion; 2018 Nov; 58(11):2657-2668. PubMed ID: 30281156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogen inactivation with amotosalen plus UVA illumination minimally impacts microRNA expression in platelets during storage under standard blood banking conditions.
    Arnason NA; Johannson F; Landrö R; Hardarsson B; Irsch J; Gudmundsson S; Rolfsson O; Sigurjonsson OE
    Transfusion; 2019 Dec; 59(12):3727-3735. PubMed ID: 31674051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogen inactivation of double-dose buffy-coat platelet concentrates photochemically treated with amotosalen and UVA light: preservation of in vitro function.
    Sandgren P; Diedrich B
    Vox Sang; 2015 May; 108(4):340-9. PubMed ID: 25557354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical and functional characteristics of stored (double-dose) buffy-coat platelet concentrates treated with amotosalen and a prototype UVA light-emitting diode illuminator.
    Brouard N; Pissenem-Rudwill F; Mouriaux C; Haas D; Galvanin A; Kientz D; Mangin PH; Isola H; Hechler B
    Transfusion; 2023 Oct; 63(10):1937-1950. PubMed ID: 37615493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro study of platelet function confirms the contribution of the ultraviolet B (UVB) radiation in the lesions observed in riboflavin/UVB-treated platelet concentrates.
    Abonnenc M; Sonego G; Crettaz D; Aliotta A; Prudent M; Tissot JD; Lion N
    Transfusion; 2015 Sep; 55(9):2219-30. PubMed ID: 25873361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiling alterations in platelets induced by Amotosalen/UVA pathogen reduction and gamma irradiation--a LC-ESI-MS/MS-based proteomics approach.
    Thiele T; Sablewski A; Iuga C; Bakchoul T; Bente A; Görg S; Völker U; Greinacher A; Steil L
    Blood Transfus; 2012 May; 10 Suppl 2(Suppl 2):s63-70. PubMed ID: 22890270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimized processing for pathogen inactivation of double-dose buffy-coat platelet concentrates: maintained in vitro quality over 7-day storage.
    Ohlsson S; Diedrich B; Uhlin M; Sandgren P
    Vox Sang; 2018 Oct; 113(7):611-621. PubMed ID: 30156292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryopreserved platelets and amotosalen-treated plasma in an experimental clot formation set-up.
    Sandgren P; Ehn K; Larsson L; Uhlin M; Wikman A
    Blood Transfus; 2023 Mar; 21(2):137-145. PubMed ID: 35302479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of procoagulant collagen- and thrombin-activated platelets in platelet concentrates derived from buffy coat: the role of processing, pathogen inactivation, and storage.
    Bertaggia Calderara D; Crettaz D; Aliotta A; Barelli S; Tissot JD; Prudent M; Alberio L
    Transfusion; 2018 Oct; 58(10):2395-2406. PubMed ID: 30229925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of refrigerated storage of UVC pathogen inactivated platelet concentrates on in vitro platelet quality parameters.
    Johnson L; Cameron M; Waters L; Padula MP; Marks DC
    Vox Sang; 2019 Jan; 114(1):47-56. PubMed ID: 30499111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Removal of citrate from PAS-III additive solution improves functional and biochemical characteristics of buffy-coat platelet concentrates stored for 7 days, with or without INTERCEPT pathogen reduction.
    Isola H; Ravanat C; Rudwill F; Pongerard A; Haas D; Eckly A; Gachet C; Hechler B
    Transfusion; 2021 Mar; 61(3):919-930. PubMed ID: 33527430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amotosalen and ultraviolet A light efficiently inactivate MERS-coronavirus in human platelet concentrates.
    Hashem AM; Hassan AM; Tolah AM; Alsaadi MA; Abunada Q; Damanhouri GA; El-Kafrawy SA; Picard-Maureau M; Azhar EI; Hindawi SI
    Transfus Med; 2019 Dec; 29(6):434-441. PubMed ID: 31696565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of cold storage on platelets treated with Intercept pathogen inactivation.
    Six KR; Devloo R; Compernolle V; Feys HB
    Transfusion; 2019 Aug; 59(8):2662-2671. PubMed ID: 31187889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Riboflavin and amotosalen photochemical treatments of platelet concentrates reduce thrombus formation kinetics in vitro.
    Van Aelst B; Feys HB; Devloo R; Vanhoorelbeke K; Vandekerckhove P; Compernolle V
    Vox Sang; 2015 May; 108(4):328-39. PubMed ID: 25557250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro evaluation of pooled buffy coat platelets treated with photochemical pathogen inactivation using amotosalen.
    Cazenave JP; Aleil B; Wiesel ML; Laforêt M; Isola H
    Vox Sang; 2004 Apr; 86(3):201-2. PubMed ID: 15078258
    [No Abstract]   [Full Text] [Related]  

  • 17. Pathogen inactivation treatment of triple-dose apheresis platelets with amotosalen and ultraviolet a light.
    Infanti L; Pehlic V; Mitrovic S; Holbro A; Andresen S; Payrat JM; Lin JS; Buser A
    Transfus Med; 2022 Dec; 32(6):505-511. PubMed ID: 36124649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro function of platelets treated with ultraviolet C light for pathogen inactivation: a comparative study with nonirradiated and gamma-irradiated platelets.
    Tynngård N; Trinks M; Berlin G
    Transfusion; 2015 Jun; 55(6):1169-77. PubMed ID: 25524519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro assessment of buffy-coat derived platelet components suspended in SSP+ treated with the INTERCEPT Blood system.
    Johnson L; Loh YS; Kwok M; Marks DC
    Transfus Med; 2013 Apr; 23(2):121-9. PubMed ID: 23480103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryopreservation of UVC pathogen-inactivated platelets.
    Waters L; Padula MP; Marks DC; Johnson L
    Transfusion; 2019 Jun; 59(6):2093-2102. PubMed ID: 30790288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.